Dataset: Expression data from human mesenchymal stem cells treated with Wnt3a

Wnt signaling is upregulated frequently in several cancers, including sarcomas. Since, there is cell-context dependent variation in the target gene expression, to identify canonical Wnt targets in sarcomas, we used human mesenchymal stem cells. Human mesenchymal stem cells were treated with 100ng/ml recombinant Wnt3a either 6 hrs or 24 hrs. Total RNA was extracted from untreated and Wnt3a treated samples using Qiagen's RNA extraction kit.

Species:

human

Samples:

3

Source:

E-GEOD-27313

Updated:

Dec.12, 2014

Registered:

Sep.15, 2014